Navigation Links
SkyePharma in Medical News

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... Pharma (TSE: 4508.T) Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T) Dermatology and Wound Index (HRW) Drop Shire PLC (ADR) (Nasdaq: SHPGY ) skyepharma Plc (LSE: SKP.LN) Add Standard Chemical & Pharm. Co., Ltd. (TSE: 1720) Taisho Pharmaceutical Co., Ltd. (TSE: 4535) Diagnostics Index (HHD) Dro...

FDA Approves ZYFLO CR(TM) (Zileuton) for Chronic Treatment of Asthma

...ory mediators in asthma that can trigger asthma symptoms, including inflammation, swelling, bronchoconstriction and mucus secretion. ZYFLO CR(TM) uses skyepharma PLC's (LSE: SKP) proprietary Geomatrix(R) drug delivery technology, which controls the amount and rate of drug released into the body. "We app...
SkyePharma in Medical Technology

Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress

...acira Pacira Pharmaceuticals, Inc. is an acute care specialty pharmaceutical company founded in March, 2007 through the acquisition of the former skyepharma PLC injectable business, for which an experienced management team was assembled to address the needs of the acute care market. The company's most adv...

U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease

...d-release, once-daily tablet formulation that uses skyepharma PLC's (LSE: SKP) patented GEOMATRIX(TM) technology... bothered enough to stop taking Requip XL. About skyepharma PLC Using its proprietary drug delivery technologies, skyepharma develops new formulations of existing products to ...

Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa

... ropinirole for treating Parkinson's disease using skyepharma Plc's proprietary GeoMatrix technology. About th...ctor about any side effects they may have. About skyepharma PLC skyepharma develops pharmaceutical products benefiting from w...

Sciele Pharma Announces Successful Completion of New Sular Formulation Clinical Trial Program

...lity of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork. About skyepharma PLC Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage and li...

SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme

...lence LONDON, UK and ATLANTA, US, May 14, 2007 - skyepharma PLC (LSE:SKP; NASDAQ:SKYE) and Sciele Pharma. Inc....tered trademark of Sciele Pharma, Inc. About skyepharma PLC Using its proprietary drug delivery technolo... related to SkyePharma's ability to manage growth. skyepharma undertakes no obligation to revise or update any s...

Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma

...ered trademark of Critical Therapeutics, Inc. ZYFLO CR(TM) is a trademark of Critical Therapeutics, Inc. Geomatrix(R) is a registered trademark of skyepharma PLC Contact Critical Therapeutics, Inc. Linda S. Lennox, 781-402-5708 Vice President, Investor & Media Relations
(Date:7/11/2014)... Shenzhen, China Researchers from Salk Institute for Biological ... time evaluated the safety and reliability of the ... a new method, TALEN-HDAdV, which could significantly increased ... (hiPSC). This study published online in Cell ... for stem cell-based gene therapy. , The combination ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2A new genome editing method brings the possibility of gene therapies closer to reality 2
Other Contents